Company profile: Vita Therapeutics
1.1 - Company Overview
Company description
- Provider of cell engineering therapies using induced pluripotent stem cells and CRISPR-based genome editing to correct genetic defects and regenerate healthy tissues. Offers VTA-100 for limb-girdle muscular dystrophy (LGMD2A), with autologous reprogramming of a patient’s blood cells and allogeneic universal iPSC lines from healthy donors engineered to evade the immune system.
Products and services
- Cell Therapy: Develops treatments using iPSCs and CRISPR-based genome editing to correct genetic defects and regenerate healthy tissues in patients
- VTA-100: Constructs a cell therapy program utilizing gene-corrected induced pluripotent stem cells to replace defective cells for limb-girdle muscular dystrophy (LGMD2A)
- Allogeneic Approach: Engineers immune-evasive universal iPSC lines from healthy donors to treat multiple patients with the same therapy
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vita Therapeutics
Memometal
HQ: France
Website
- Description: Provider of surgical implants for orthopedic surgeries, designing, developing, manufacturing, and marketing these products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Memometal company profile →
Tornier
HQ: The Netherlands
Website
- Description: Provider of medical devices serving surgeons who treat musculoskeletal injuries and disorders, with a global focus.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tornier company profile →
Progentix
HQ: The Netherlands
Website
- Description: Provider of synthetic bone substitutes designed to accelerate bone healing through a novel microstructure, with offerings related to the spine, spinal medical devices, and minimally invasive surgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Progentix company profile →
Zavation
HQ: United States
Website
- Description: Provider of medical device and biologic products for spinal surgeries from an employee-owned company, designing, developing, manufacturing and distributing solutions including eZspand® expandable lumbar interbody fusion device, Multitude Fiber, UnifuZe-P, Zavatrix – Viable Allograft, Cervical Allograft, and CoreLink DBM demineralized bone matrix to improve patient quality of life.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zavation company profile →
DePuy Synthes
HQ: United States
Website
- Description: Provider of orthopedic and medtech equipment supporting healing and restoring movement. Offerings span joint reconstruction, trauma, craniomaxillofacial, spinal surgery, and sports medicine, plus ASC capabilities, advanced case management, loaner programs, matrixrib care, and orthopaedic education through the Johnson & Johnson Institute.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DePuy Synthes company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vita Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vita Therapeutics
2.2 - Growth funds investing in similar companies to Vita Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vita Therapeutics
4.2 - Public trading comparable groups for Vita Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →